Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Seminars in Oncology|April 1, 2005
Unraveling biologic therapy for Bcl-2-expressing malignanciesFinbarr E CotterBritish Journal of Haematology|May 10, 2007
The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafishRebecca L Auer, Sophia Riaz, Finbarr E CotterBritish Journal of Haematology|October 27, 2007
Emerging therapy for chronic lymphocytic leukaemiaRebecca L Auer, John Gribben, Finbarr E CotterBritish Journal of Haematology|June 29, 2016
Can exome scans be expected to be part of real-time decision-making in patients with haematological cancers?Peter Hokland, Finbarr E Cotter, Marcus C HansenClinical Lymphoma|November 19, 2002
Mantle cell lymphoma: new treatments targeted to the biologyFrancesco Bertoni, Michele Ghielmini, Franco Cavalli, et al.Biochemical and Biophysical Research Communications|August 8, 2007
Cell death in leukemia: passenger protein regulation by topoisomerase inhibitorsUlrike Jahnke, Karen Higginbottom, Adrian C Newland, et al.Apoptosis : an International Journal on Programmed Cell Death|July 20, 2007
New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosisKaren Higginbottom, Ulrike Jahnke, Adrian C Newland, et al.Proteome Science|September 1, 2009
Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrixFrédéric Delom, Emma Burt, Alex Hoischen, et al.American Journal of Obstetrics and Gynecology|January 24, 2007
Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxiaCathal McCarthy, Finbarr E Cotter, Suzanne McElwaine, et al.Blood|March 2, 2010
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell deathMatthew J Streetly, Lenushka Maharaj, Simon Joel, et al.Pageof 3